Hyperthermic intraoperative intraperitoneal chemotherapy safety considerations.
Perioperative staff members encounter many occupational exposure hazards in the workplace. Cytotoxic agent exposure is a relatively new hazard that perioperative staff members are experiencing as more surgeons use hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) to treat patients with abdominopelvic cavity malignancies. Routes of exposure include inhalation, ingestion, injection, and skin contact. The National Cancer Institute, the Occupational Safety and Health Administration, and the Joint Commission on Accreditation of Healthcare Organizations provide guidelines for the safe administration and handling of cytotoxic agents. Institutions in which cytotoxic agents are administered should use these guidelines to develop policies, procedures, and educational programs to protect surgical patients and perioperative staff members.
White
S K
SK
Department of General Surgery/Shock-Trauma, Perioperative Clinical Nursing Division, Washington (DC) Hospital Center, USA.
Stephens
A D
AD
Sugarbaker
P H
PH
D000008:Abdominal Neoplasms / Q000188:drug therapy* / Q000451:nursing / Q000601:surgery*; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D003131:Combined Modality Therapy; D006358:Hot Temperature; D006801:Humans; D007263:Infusions, Parenteral; D008506:Medical Waste; D016273:Occupational Exposure; D013527:Perioperative Nursing / Q000458:organization & administration; D012449:Safety
D000970:Antineoplastic Agents; D008506:Medical Waste